You are here: Industry Insights > Hypotension

News List

FDA Approves Rezipres (ephedrine hydrochloride injection) for Hypotension During Anesthesia drugs
June 16, 2021
Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that FDA has approved Rezipres (ephedrine hydrochloride injection) for the treatment of clinically important hypotension occurring in the setting of anesthesia.
Caplin Steriles gets USFDA approval for Phenylephrine Hydrochloride Injection USP expresspharma
June 16, 2020
It is indicated for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anaesthesia.
Eton Announces Commercial Availability of Biorphen Injection americanpharmaceuticalreview
December 30, 2019
Eton Pharmaceuticals announced Biorphen®, the first and only FDA-approved ready-to-use formulation of phenylephrine for the treatment of clinically important hypotension ...
Lower Systolic BP Goal May Cut Risk for Orthostatic Hypotension drugs
September 10, 2019
In adults with recent stroke, a lower systolic blood pressure (SBP) goal may reduce the risk for orthostatic hypotension (OH) without any effect on orthostatic symptoms...